Pola Dan Uji Sensitivitas Kuman Terhadap Antibiotika Pada Penderita Otitis Media Supuratif Kronis (Omsk) Rawat Jalan Di Rumah Sakit Umum Daerah Dr. Moewardi Periode Januari – Juli 2015
| Main Author: | Permataningtyas, Yasinta Dian |
|---|---|
| Format: | Karya Ilmiah NonPeerReviewed application/pdf |
| Bahasa: | eng |
| Terbitan: |
, 2015
|
| Subjects: | |
| Online Access: |
http://eprints.ums.ac.id/40984/1/NASKAH%20PUBLIKASI.pdf http://eprints.ums.ac.id/40984/2/COVER-HALAMAN%20DEPAN.pdf http://eprints.ums.ac.id/40984/3/BAB%201.pdf http://eprints.ums.ac.id/40984/5/BAB%202.pdf http://eprints.ums.ac.id/40984/7/BAB%203.pdf http://eprints.ums.ac.id/40984/8/BAB%204.pdf http://eprints.ums.ac.id/40984/9/DAFTAR%20PUSTAKA.pdf http://eprints.ums.ac.id/40984/10/LAMPIRAN.pdf http://eprints.ums.ac.id/40984/11/SURAT%20PERNYATAAN%20PUBLIKASI.pdf http://eprints.ums.ac.id/40984/ |
Daftar Isi:
- Chronic suppurative otitis media (CSOM) is a chronic infection of the middle ear due to perforation of the tympanic membrane in which the secretion gradually appear or intermittent. This study was aimed at to determine the pattern of microbose, the sensitivity test of the microbes toward antibiotics and the rational usage of antibiotics for the CSOM outpatent at RSUD Dr. Moewardi in January to July 2015. This study was categorized as non-experimental research. The analysis was done by using descriptive method. The research was conducted at RSUD Dr. Moewardi and the data were obtained from the outpatients who did microbes’ cultur in January to July 2015. The most dominant microbes found from 47 CSOM patients who did treatment and cultur at RSUD Dr. Moewardi in January to July 2015 were Pseudomonas aeruginosa (51.92%), Proteus mirabilis (21.15%), and Staphylococcus aureus (6.38%). The sensitivity results show that Pseudomonas aeruginosa microbes (24 patients) were sensitive toward meropenem antibiotic (100%), amikacin (81.48%), cefepime (74.07%) and Proteus mirabilis bacteria. In addition, nine (9) patients were sensitive toward meropenem antibiotic (100%), amikacin (100%), ceftriaxone (90.91%), cefepime (81.82%) and gentamicin (81.82%). The accuracy of the laboratorium result compared to the treatment is 46,80%, mean while the appropriateness of the therapy with the laboratorium results compared to the RSUD Dr. Moewardi regulation in the period of 2011-2012 was 23.40%.